BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 5, 2009
View Archived Issues
If This Is a 'V-Shaped'Recovery, Is That 'Victory' or 'Vanquished?'
Read More
New Studies Report Getting iPS Cells from Cord Blood
Read More
Pair Lighting 'Fuzeon' Merger; Trimeris, Korean Firm to Join From
Read More
Clinic Roundup
Read More
Stimulating Recovery Ahead? $5B in Fed Funds to Dole Out
Read More
Financings News
Read More
Other News to Note
Read More
Oncolytics' Phase III Borrows Adaptive Design in SPA Trial
Oncolytics Biotech Inc. reached agreement with the FDA on the design of a Phase III trial of Reolysin in head and neck cancer, marking the first such agreement for an intravenously administered oncolytic virus. (BioWorld Today)
Read More
QLT Sheds Few Eligard Tears, Turns Eye to Punctal-Plug Bid
Read More
